FDA Grants Orphan-Drug Designation for Novel Terlipressin Formulation for the …

Published January 10, 2013

FDA Grants Orphan-Drug Designation for Novel Terlipressin Formulation for the …

Filed under: Drug Treatment Chicago

… Wash. and CHICAGO, Jan. 4, 2013 /PRNewswire/ — PharmaIN Corporation and LAT Pharma LLC today announced that the US Food and Drug Administration (FDA) has granted their request for orphan-drug designation for terlipressin for the treatment of …
Read more on PR Newswire (press release)

This Stock Could be Perfect for the "Dividend Decade"

Filed under: Drug Treatment Chicago

Second, because of Humira's proven track record and dominant share in the market for rheumatoid arthritis drugs, physicians will probably continue to utilize Humira as a first-line treatment even after generic versions are launched. Third, overall …
Read more on StreetAuthority